These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 19766525)

  • 1. [Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas].
    Laprie A
    Cancer Radiother; 2009 Oct; 13(6-7):556-61. PubMed ID: 19766525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma.
    Chang J; Thakur SB; Huang W; Narayana A
    Technol Cancer Res Treat; 2008 Oct; 7(5):349-62. PubMed ID: 18783284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
    Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
    Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the functional imaging modalities in radiation therapy treatment planning in patients with glioblastoma].
    Dhermain F; Ducreux D; Bidault F; Bruna A; Parker F; Roujeau T; Beaudre A; Armand JP; Haie-Meder C
    Bull Cancer; 2005 Apr; 92(4):333-42. PubMed ID: 15888390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
    Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
    Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Image registration for radiation therapy: Practical aspects and quality control].
    Bonniaud G; Isambert A; Dhermain F; Beaudré A; Ferreira I; Ricard M; Lefkopoulos D
    Cancer Radiother; 2006 Sep; 10(5):222-30. PubMed ID: 16890471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Li FM; Nie Q; Wang RM; Chang SM; Zhao WR; Zhu Q; Liang YK; Yang P; Zhang J; Jia HW; Fang HH
    Nucl Med Biol; 2012 Apr; 39(3):437-42. PubMed ID: 22172386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of FET-PET imaging for target volume definition in patients with gliomas treated with conformal radiotherapy.
    Rieken S; Habermehl D; Giesel FL; Hoffmann C; Burger U; Rief H; Welzel T; Haberkorn U; Debus J; Combs SE
    Radiother Oncol; 2013 Dec; 109(3):487-92. PubMed ID: 23953407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI.
    Nelson SJ; Graves E; Pirzkall A; Li X; Antiniw Chan A; Vigneron DB; McKnight TR
    J Magn Reson Imaging; 2002 Oct; 16(4):464-76. PubMed ID: 12353260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to use functional imaging information for radiotherapy planning.
    Grosu AL; Nestle U; Weber WA
    Eur J Cancer; 2009 Sep; 45 Suppl 1():461-3. PubMed ID: 19775672
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches.
    Dhermain F
    Chin J Cancer; 2014 Jan; 33(1):16-24. PubMed ID: 24384237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of MR spectroscopy and functional imaging in the treatment planning of gliomas.
    Narayana A; Chang J; Thakur S; Huang W; Karimi S; Hou B; Kowalski A; Perera G; Holodny A; Gutin PH
    Br J Radiol; 2007 May; 80(953):347-54. PubMed ID: 17068012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional magnetic resonance imaging for defining the biological target volume.
    Kauczor HU; Zechmann C; Stieltjes B; Weber MA
    Cancer Imaging; 2006 Jun; 6(1):51-5. PubMed ID: 16766269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronologic dynamics of the "triple ring," caused by interstitial Iodine-125 brachytherapy with a novel method of image fusion].
    Kolumbán Z; Viola A; Major T; Bajzik G; Julow J
    Ideggyogy Sz; 2008 Mar; 61(3-4):106-13. PubMed ID: 18459451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
    Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
    J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
    Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
    Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases.
    Floeth FW; Wittsack HJ; Engelbrecht V; Weber F
    Zentralbl Neurochir; 2002; 63(1):23-8. PubMed ID: 12098080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.